Описание деятельности
Dexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world.
Правление & Наблюдательный совет
| Исполнительный директор |
| Kevin Sayer |
| Правление |
| Jereme Sylvain, Andrew K. Balo, Barry Regan, Chad Patterson, Don Abbey, Jake Leach, Paul Flynn, Sadie Stern, Shelly Selvaraj, Steven R. Pacelli, Sumi Shrishrimal |
| Наблюдательный совет |
| Kevin Sayer, Barbara E. Kahn, Bridgette Heller, Eric J. Topol, M.D., Jay Skyler, M.D., Karen Dahut, Kyle Malady, Mark Foletta, Nick Augustinos, Richard Collins, Steven R. Altman |
Данные компании
| Имя: |
Dexcom Inc. |
| Адрес: |
6340 Sequence Drive,San Diego, CA 92121, USA |
| Телефон: |
+1-858-200-0200 |
| Факс: |
- |
| E-mail: |
-
|
| Интернет: |
https://www.dexcom.com/ |
| Индустрия: |
Biotechnology |
| Сектор: |
Biotechnology |
| Подсектор: |
Biotechnology |
| Конец финансового года: |
31.12 |
| Акции в свободном обращении: |
- |
| Дата IPO: |
- |
